𝐌𝐨𝐥𝐞𝐚𝐜 𝐚𝐭 𝐭𝐡𝐞 𝟏𝟕ᵗʰ 𝐀𝐧𝐧𝐮𝐚𝐥 𝐂𝐨𝐧𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫’𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐏𝐡𝐢𝐥𝐢𝐩𝐩𝐢𝐧𝐞𝐬!
Over the last weekend, Moleac attended the 17ᵗʰ Annual Convention of the Alzheimer’s Disease Association of the Philippines together with our valued partner in the Philippines, E*Chi’mes Pharmaceutical Inc.

This year, the theme was “Silver Linings: Connecting the Dots in Dementia Care”. Through the two-day event, dementia specialists, allied health professionals, industry partners and more from all over the country were brought together to discuss the latest developments in the rapidly-evolving field of Alzheimer’s Disease research, share knowledge and foster deeper relationships.

Dr. Donnabelle M. Chu, specialist neurologist in Behavioral Neurology & Dementia, delivered a presentation on “The Role of NeuroAiD in the Management of Alzheimer’s Disease: Exploring Safety, Efficacy and Potential Disease-Modifying Effect” during the lunch symposium on Day 2 of the convention, summarizing the pre-clinical data and clinical trial results on NeuroAiD in Alzheimer’s Disease. Her presentation was warmly received and encouraged a lively discussion on the potential of NeuroAiD in dementia. Afterwards, our CEO David Picard delivered a rousing speech on how NeuroAiD can play an important role in the treatment toolkit for Alzheimer’s Disease.

Moleac was honoured to be given the opportunity to connect with the multi-disciplinary network of dementia specialists attending the conference and to work together with the dementia community at large to advance care in Alzheimer’s Disease.

We would like to thank E*Chi’mes Pharmaceutical Inc for your continued partnership and commitment to patient care.

Learn more about our role in Alzheimer’s Disease care at moleac.com.